HedgeChatter

  • Home /
  • Tag Archives

color

10 Biotech Stocks With Catalysts Coming Soon – Benzinga

Related CLVSClovis Oncology Could Pass $100 By Year-End: Here’s WhyClovis Oncology Completes US, EU Regulatory Submissions for Rociletinib for Treatment of Advanced EGFR-Mutant T790M+ NSCLCClovis Oncology: Don’t Discount Rociletinib’s Chances Against AZD9291(Seeking Alpha)Related EPZMBenzinga’s Top DowngradesH.C. Wainwright Destroys Epizyme Price Target, Sees ‘No Material Value Drivers’A new report by Mizuho analyst Peter Lawson focuses on biotech stocks with major catalysts […]

August 20, 2015 ByWayne Duggan , , , , , , , , , , Comments Off on 10 Biotech Stocks With Catalysts Coming Soon – Benzinga read more

Stock Market Cycle Big Picture :: The Market Oracle :: Financial …

Stock Market Cycle Big PictureStock-Markets / Stock Markets 2015Jun 12, 2015 – 03:36 PM GMTBy: Gary_TanashianIn the previous post Tom McClellan highlights Peter Eliades’ work on the cyclical top due in the S&P 500 this year. To add some color to it, here is the chart I produced for NFTRH subscribers several weeks ago after purchasing and reading an Eliades […]

June 12, 2015 Byunknown , , , , , , , , , , Comments Off on Stock Market Cycle Big Picture :: The Market Oracle :: Financial … read more

Stifel Talks 5 Biotech Stocks – ARIAD Pharmaceuticals, Inc …

Related ARIAMorning Market GainersBenzinga’s Top #PreMarket GainersThe Vetr community has downgraded $ARIA to 3-Stars(Vetr)Related CLVSGoldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis OncologyBenzinga’s Volume MoversStifel analyst Brian Klein published abstracts Thursday from the 2015 ASCO annual meeting.Klein’s following comments along with current ratings were intended to provide investors with “meaningful insight into ongoing clinical activities for various […]

May 14, 2015 ByKevin Riley , , , , , , , , Comments Off on Stifel Talks 5 Biotech Stocks – ARIAD Pharmaceuticals, Inc … read more

Expert: Biogen Is Closing In On The 'Holy Grail' For Biotech Stocks …

Related BIIBBiogen Continues To Decline After Friday’s RoutDid The AAN Meeting Affect Biogen, PTC Therapeutics, GW Pharma Or Isis Pharma?Synageva Q1 Loss Narrower-than-Expected, Pipeline in Focus – Analyst Blog(Zacks)In this week’s episode, Estimize is joined by Joe McCann, a former biotech analyst at CR Intrinsic and the CEO of Slingshot Insights.In the episode, Joe discusses Biogen Inc (NASDAQ: BIIB) new […]

April 30, 2015 ByLeigh Drogen , , , , , , , , , , Comments Off on Expert: Biogen Is Closing In On The 'Holy Grail' For Biotech Stocks … read more

UPDATE: JMP Securities Downgrades Nice-Systems As Risk/Return …

Related NICEImperial Capital Rates Raft Of Security Companies At Mostly OutperformWedbush Remains Positive On NICE Systems After Management MeetingsIn a report published Tuesday, JMP Securities analyst Greg McDowell downgraded the rating on Nice-Systems Ltd. (ADR) (NASDAQ: NICE) from Market Outperform to Market Perform, and removed the $58.00 price target.In the report, JMP Securities noted, “We are downgrading NICE Systems to […]

March 24, 2015 ByDwight Einhorn , , , , , , , , Comments Off on UPDATE: JMP Securities Downgrades Nice-Systems As Risk/Return … read more

Robinhood App Review: Hands On with the No-Fee, No-Minimum …

This week, we take a hands-on look at the new iOS app Robinhood, a unique, mobile-first take on stock market trading that’s poised to be a big hit with millennials.Robinhood an apt name for the recently launched stock-trading app made by Robinhood Financial, Inc. — a company whose goal isn’t to rob the rich and give to the poor, but […]

March 17, 2015 Byunknown , , , , , , , , Comments Off on Robinhood App Review: Hands On with the No-Fee, No-Minimum … read more

Barclays Expands Coverage To 7 New Biotech Stocks – Achillion …

Related ACHNAfter-Hours Movers Led By Bob Evans, Bazaarvoice And Smith & Wesson On TuesdayTop 5 Biotech Stocks That The Smart Money Doesn’t LikeAchillion Pharma updates guidance after Q4 results(Seeking Alpha)Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham.Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at […]

March 4, 2015 ByKevin Riley , , , , , , , , , , Comments Off on Barclays Expands Coverage To 7 New Biotech Stocks – Achillion … read more